Report cover image

Live Attenuated Polio Vaccine Global Market Report 2025

Published Jul 01, 2025
Length 175 Pages
SKU # BRC20148726

Description

Live Attenuated Polio Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on live attenuated polio vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for live attenuated polio vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The live attenuated polio vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Vaccine Type: Monovalent; Bivalent; Trivalent

2) By Administration Route: Oral Administration; Intramuscular Injection; Subcutaneous Injection

3) By Age Group: Infants (0-1 years); Children (1-5 years); Adults (Above 5 years)

4) By End-User: Hospitals; Clinics; Public Health Agencies; Other End-Users

Subsegments:

1) Monovalent: mOPV1 For Serotype 1

2) Bivalent: Type 1; Type 3

3) Trivalent: Poliovirus Type 1; Poliovirus Type 2; Poliovirus Type 3

Companies Mentioned: Sanofi Pasteur; GlaxoSmithKline plc; LG Chem Ltd.; Serum Institute of India Pvt. Ltd.; Biological E. Limited

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

175 Pages
1. Executive Summary
2. Live Attenuated Polio Vaccine Market Characteristics
3. Live Attenuated Polio Vaccine Market Trends And Strategies
4. Live Attenuated Polio Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Live Attenuated Polio Vaccine Growth Analysis And Strategic Analysis Framework
5.1. Global Live Attenuated Polio Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Live Attenuated Polio Vaccine Market Growth Rate Analysis
5.4. Global Live Attenuated Polio Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Live Attenuated Polio Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Live Attenuated Polio Vaccine Total Addressable Market (TAM)
6. Live Attenuated Polio Vaccine Market Segmentation
6.1. Global Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monovalent
Bivalent
Trivalent
6.2. Global Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Administration
Intramuscular Injection
Subcutaneous Injection
6.3. Global Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infants (0-1 years)
Children (1-5 years)
Adults (Above 5 years)
6.4. Global Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Public Health Agencies
Other End-Users
6.5. Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
mOPV1 For Serotype 1
6.6. Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Bivalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Type 1
Type 3
6.7. Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Trivalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Poliovirus Type 1
Poliovirus Type 2
Poliovirus Type 3
7. Live Attenuated Polio Vaccine Market Regional And Country Analysis
7.1. Global Live Attenuated Polio Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Live Attenuated Polio Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Live Attenuated Polio Vaccine Market
8.1. Asia-Pacific Live Attenuated Polio Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Live Attenuated Polio Vaccine Market
9.1. China Live Attenuated Polio Vaccine Market Overview
9.2. China Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Live Attenuated Polio Vaccine Market
10.1. India Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Live Attenuated Polio Vaccine Market
11.1. Japan Live Attenuated Polio Vaccine Market Overview
11.2. Japan Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Live Attenuated Polio Vaccine Market
12.1. Australia Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Live Attenuated Polio Vaccine Market
13.1. Indonesia Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Live Attenuated Polio Vaccine Market
14.1. South Korea Live Attenuated Polio Vaccine Market Overview
14.2. South Korea Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Live Attenuated Polio Vaccine Market
15.1. Western Europe Live Attenuated Polio Vaccine Market Overview
15.2. Western Europe Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Live Attenuated Polio Vaccine Market
16.1. UK Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Live Attenuated Polio Vaccine Market
17.1. Germany Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Live Attenuated Polio Vaccine Market
18.1. France Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Live Attenuated Polio Vaccine Market
19.1. Italy Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Live Attenuated Polio Vaccine Market
20.1. Spain Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Live Attenuated Polio Vaccine Market
21.1. Eastern Europe Live Attenuated Polio Vaccine Market Overview
21.2. Eastern Europe Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Live Attenuated Polio Vaccine Market
22.1. Russia Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Live Attenuated Polio Vaccine Market
23.1. North America Live Attenuated Polio Vaccine Market Overview
23.2. North America Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Live Attenuated Polio Vaccine Market
24.1. USA Live Attenuated Polio Vaccine Market Overview
24.2. USA Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Live Attenuated Polio Vaccine Market
25.1. Canada Live Attenuated Polio Vaccine Market Overview
25.2. Canada Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Live Attenuated Polio Vaccine Market
26.1. South America Live Attenuated Polio Vaccine Market Overview
26.2. South America Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Live Attenuated Polio Vaccine Market
27.1. Brazil Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Live Attenuated Polio Vaccine Market
28.1. Middle East Live Attenuated Polio Vaccine Market Overview
28.2. Middle East Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Live Attenuated Polio Vaccine Market
29.1. Africa Live Attenuated Polio Vaccine Market Overview
29.2. Africa Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Live Attenuated Polio Vaccine Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Live Attenuated Polio Vaccine Market Competitive Landscape And Company Profiles
30.1. Live Attenuated Polio Vaccine Market Competitive Landscape
30.2. Live Attenuated Polio Vaccine Market Company Profiles
30.2.1. Sanofi Pasteur Overview, Products and Services, Strategy and Financial Analysis
30.2.2. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
30.2.3. LG Chem Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Serum Institute of India Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Biological E. Limited Overview, Products and Services, Strategy and Financial Analysis
31. Live Attenuated Polio Vaccine Market Other Major And Innovative Companies
31.1. Indian Immunologicals Limited
31.2. Sinovac Biotech Ltd.
31.3. Shenzhen Kangtai Biological Products Co. Ltd.
31.4. Vabiotech
31.5. Emergent BioSolutions Inc.
31.6. Valneva SE
31.7. Bio Farma
31.8. PT Bio Farm
31.9. Bilthoven Bio
31.10. Panacea Biotec
31.11. Haffkine Biopharmaceutical
31.12. Panacea Biotec Ltd.
31.13. Zydus Cadila
31.14. Liaoning Cheng Da Biotechnology Co.Ltd
31.15. Bharat Biotech International Limited
32. Global Live Attenuated Polio Vaccine Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Live Attenuated Polio Vaccine Market
34. Recent Developments In The Live Attenuated Polio Vaccine Market
35. Live Attenuated Polio Vaccine Market High Potential Countries, Segments and Strategies
35.1 Live Attenuated Polio Vaccine Market In 2029 - Countries Offering Most New Opportunities
35.2 Live Attenuated Polio Vaccine Market In 2029 - Segments Offering Most New Opportunities
35.3 Live Attenuated Polio Vaccine Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.